mucosal tuberculosis vaccines (rhPIV2 vector ) (NIBIO/Aeras/Create Vaccine)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemucosal tuberculosis vaccines (rhPIV2 vector ) (NIBIO/Aeras/Create Vaccine)
Drug Alias Namemucosal tuberculosis vaccines (rhPIV2 vector) (NIBIO/Aeras/Create Vaccine)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Biomedical Innovation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCreate Vaccine CoNational Institute Of Biomedical InnovationAeras
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A